Marzena Flasza-Baron

Services

Information

An overview of Cell and Gene Therapy Catapult capabilities includes: 1/ ATMP process development optimisation and scale up 2/ Analytical development and Process Analytical Technologies (PAT) enabling process digitalization 3/ High-throughput manufacturing automation and robotics 4/ Formulation (cryopreservation) and final fill-finish 5/ Establishing and optimisation of GMP manufacturing and supply chain 6/ Clinical adoption including CMC gap analysis, non-clinical safety, regulatory (MHRA, EMA, FDA), health economics and market access, pricing and reimbursement, clinical development including clinical trials design
Cell and Gene Therapy CatapultNO STANDThe Cell and Gene Therapy Catapult is an independent innovation and technology organisation committed to the advancement of the cell and gene therapy industry with a vision of a thriving industry delivering life changing advanced therapies to the world. Its aim is to create powerful collaborations which overcome challenges to the advancement of the sector.